$IRTC

Smith Mervin sold $75K of IRTC

Smith Mervin (EVP Strategic Business Ops) sold 617 shares of iRhythm Holdings, Inc. (IRTC) at $122.12 on 2026-08-03.

Original reporting
SEC EDGAR · Smith Mervin
Published Aug 4, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 6:24 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IRTC
Neutral
high confidence
Mentioned
$IRTC
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IRTCNeutralLow
01

Why it matters

The only new fact is the insider sale details (shares, price, total value, post-transaction holdings). There is no accompanying company-specific catalyst such as guidance, contract, or regulatory action.

02

Market read

Traders may note insider selling, but the disclosed transaction is small and lacks fundamental implications.

03

What to watch

The filing states no pre-arranged 10b5-1 plan, but it does not provide intent, tax context, or whether other insiders are selling/buying around the same period.

Relevance 3/10Novelty 2/10Timing: filed 2026-08-04, transaction dated 2026-08-03

Background

The article is an SEC Form 4 insider transaction disclosure for iRhythm Holdings, Inc.

Company-level read

Ticker impact

$IRTCNeutralHigh confidence
Context

iRhythm Holdings Form 4 shows EVP Strategic Business Ops Smith Mervin sold 617 shares on 2026-08-03 for about $75.3K.

Expected impact

Low near-term impact; any price reaction would be more sentiment-driven than fundamentals-driven.

Evidence & confidence

The filing is a Form 4 insider transaction, not an earnings, guidance, deal, or regulatory event. The transaction value (~$75K) is modest relative to typical company market caps, and the article provides no new operational or financial information.

Market effects

No clear sector read-through from a single small insider sale.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs, so the signal may be overstated.

Key entities

  • iRhythm Holdings, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Smith Mervin

    EVP Strategic Business Ops who sold 617 shares in an open-market transaction.

Related articles

$IRTCMedAI 8/10

Why iRhythm (IRTC) Stock Is Trading Up Today

iRhythm Technologies (IRTC) shares rose about 2% after the company reported Q2 results that beat expectations and lifted full-year revenue guidance. Revenue was $224.2 million, up 20.1% year over year. EPS was $0.58 versus $0.00 consensus. Full-year revenue guidance was raised to $885 million at the midpoint.

$IRTCHigh

iRhythm Holdings, Inc. (IRTC): Results of Operations and Financial Condition

iRhythm Holdings, Inc. (IRTC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 irtcq22026ex991pressrelease.htm EX-99.1 Document Exhibit 99.1 iRhythm Holdings Announces Second Quarter 2026 Financial Results SAN FRANCISCO, August 6, 2026 -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solut

$IRTCMedAI 8/10

iRhythm Investigates Cyber Incident After Hackers Claim Access To Sensitive Data - iRhythm Holdings (NASD

iRhythm Holdings said in an SEC filing that it launched its cybersecurity response after detecting suspicious activity and hired external advisors to investigate a claimed hack. The threat actor alleged access to proprietary data and patient-protected health and personal information and demanded payment. iRhythm confirmed some data was exfiltrated from third-party-hosted apps and deemed the incident material as of June 10, 2026, while saying core operations and patient safety were unaffected.